Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Rifabutin Triple Therapy for First-line and Rescue Treatment of Helicobacter Pylori Infection

NCT04652284 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT04652284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04652284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Rifabutin Triple Therapy for First-line and Rescue Treatment of Helicobacter Pylori Infection
Lead sponsor
Rabin Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
May 1, 2021
Completion date
July 31, 2023
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastritis h pylori, helicobacter infections, resistance bacterial